Goldman Sachs’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,220	Closed	-$55K	–	5435
2022 Q3	$55K	Sell	11,220 -3,065	-21%	-$15K	﹤0.01%	5025
2022 Q2	$133K	Buy	14,285 +1,484	+12%	+$13.8K	﹤0.01%	5029
2022 Q1	$82K	Buy	12,801 +2,114	+20%	+$13.5K	﹤0.01%	5367
2021 Q4	$92K	Buy	+10,687	New	+$92K	﹤0.01%	5243